These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 7589876)

  • 1. Effect of cilostazol on experimental diabetic neuropathy in the rat.
    Kihara M; Schmelzer JD; Low PA
    Diabetologia; 1995 Aug; 38(8):914-8. PubMed ID: 7589876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cilostazol on development of experimental diabetic neuropathy: functional and structural studies, and Na+ -K+ -ATPase acidity in peripheral nerve in rats with streptozotocin-induced diabetes.
    Naka K; Sasaki H; Kishi Y; Furuta M; Sanke T; Nanjo K; Mukoyama M
    Diabetes Res Clin Pract; 1995 Dec; 30(3):153-62. PubMed ID: 8861454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cilostazol on the neuropathies of streptozotocin-induced diabetic rats.
    Suh KS; Oh SJ; Woo JT; Kim SW; Yang IM; Kim JW; Kim YS; Choi YK; Park IK
    Korean J Intern Med; 1999 Jul; 14(2):34-40. PubMed ID: 10461423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nerve function and blood flow in Otsuka Long-Evans Tokushima Fatty rats with sucrose feeding: effect of an anticoagulant.
    Hotta N; Koh N; Sakakibara F; Nakamura J; Hamada Y; Hara T; Mori K; Naruse K; Fukasawa H; Kakuta H; Sakamoto N
    Eur J Pharmacol; 1996 Oct; 313(3):201-9. PubMed ID: 8911916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a potent new aldose reductase inhibitor, (5-(3-thienyltetrazol-1-yl)acetic acid (TAT), on diabetic neuropathy in rats.
    Hotta N; Kakuta H; Fukasawa H; Koh N; Sakakibara F; Nakamura J; Hamada Y; Wakao T; Hara T; Mori K
    Diabetes Res Clin Pract; 1995 Feb; 27(2):107-17. PubMed ID: 7607048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy.
    Nagamatsu M; Nickander KK; Schmelzer JD; Raya A; Wittrock DA; Tritschler H; Low PA
    Diabetes Care; 1995 Aug; 18(8):1160-7. PubMed ID: 7587852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of adenosine and adenosine A2A receptor agonist on motor nerve conduction velocity and nerve blood flow in experimental diabetic neuropathy.
    Kumar S; Arun KH; Kaul CL; Sharma SS
    Neurol Res; 2005 Jan; 27(1):60-6. PubMed ID: 15829161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II receptor blockade improves nerve function, modulates nerve blood flow and stimulates endoneurial angiogenesis in streptozotocin-diabetic rats and nerve function.
    Maxfield EK; Cameron NE; Cotter MA; Dines KC
    Diabetologia; 1993 Dec; 36(12):1230-7. PubMed ID: 8307249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cilostazol on the peripheral nerve function and structure in STZ-induced diabetic rats.
    Uehara K; Sugimoto K; Wada R; Yoshikawa T; Marukawa K; Yasuda Y; Kimura Y; Yagihashi S
    J Diabetes Complications; 1997; 11(3):194-202. PubMed ID: 9174902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy.
    Stevens MJ; Obrosova I; Cao X; Van Huysen C; Greene DA
    Diabetes; 2000 Jun; 49(6):1006-15. PubMed ID: 10866054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy.
    Kumar A; Kaundal RK; Iyer S; Sharma SS
    Life Sci; 2007 Mar; 80(13):1236-44. PubMed ID: 17289084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-L-carnitine administration.
    Pop-Busui R; Marinescu V; Van Huysen C; Li F; Sullivan K; Greene DA; Larkin D; Stevens MJ
    Diabetes; 2002 Aug; 51(8):2619-28. PubMed ID: 12145179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tanshinone IIA improves impaired nerve functions in experimental diabetic rats.
    Liu Y; Wang L; Li X; Lv C; Feng D; Luo Z
    Biochem Biophys Res Commun; 2010 Aug; 399(1):49-54. PubMed ID: 20637731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats.
    Cameron NE; Cotter MA; Archibald V; Dines KC; Maxfield EK
    Diabetologia; 1994 May; 37(5):449-59. PubMed ID: 8056181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered vasoreactivity to angiotensin II in experimental diabetic neuropathy: role of nitric oxide.
    Kihara M; Mitsui MK; Mitsui Y; Okuda K; Nakasaka Y; Takahashi M; Schmelzer JD
    Muscle Nerve; 1999 Jul; 22(7):920-5. PubMed ID: 10398211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological manipulation of vascular endothelium function in non-diabetic and streptozotocin-diabetic rats: effects on nerve conduction, hypoxic resistance and endoneurial capillarization.
    Cameron NE; Cotter MA; Dines KC; Maxfield EK
    Diabetologia; 1993 Jun; 36(6):516-22. PubMed ID: 8335173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of M40403 treatment of diabetic rats on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve.
    Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Lund DD; Salvemini D; Yorek MA
    Br J Pharmacol; 2001 Sep; 134(1):21-9. PubMed ID: 11522593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventive and curative effect of edaravone on nerve functions and oxidative stress in experimental diabetic neuropathy.
    Saini AK; Kumar H S A; Sharma SS
    Eur J Pharmacol; 2007 Jul; 568(1-3):164-72. PubMed ID: 17521626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cause and effect of ischaemia in chronic experimental diabetic neuropathy.
    Low P; Kihara M; Cameron N; Cotter M; Poduslo J
    Diabet Med; 1993; 10 Suppl 2():52S-55S. PubMed ID: 8334844
    [No Abstract]   [Full Text] [Related]  

  • 20. Pentoxifylline effects on nerve conduction velocity and blood flow in diabetic rats.
    Flint H; Cotter MA; Cameron NE
    Int J Exp Diabetes Res; 2000; 1(1):49-58. PubMed ID: 11469390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.